Search Results - "Potter, G A"

Refine Results
  1. 1
  2. 2
  3. 3

    A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism by Potter, G A, McCague, R, Jarman, M

    Published in Carcinogenesis (New York) (01-03-1994)
    “…A mechanism for the generation of electrophilic alkylating agents from tamoxifen by hepatic alpha-oxidation of its ethyl group is presented which accounts for…”
    Get more information
    Journal Article
  4. 4

    Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates alpha-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen by Phillips, D H, Potter, G A, Horton, M N, Hewer, A, Crofton-Sleigh, C, Jarman, M, Venitt, S

    Published in Carcinogenesis (New York) (01-08-1994)
    “…A proposed mechanism for the metabolic activation of tamoxifen to electrophilic species that form DNA adducts leading to liver cancer involves…”
    Get more information
    Journal Article
  5. 5

    Non-haematological solid tumours as surrogate granulocytes: a possible mechanism for metastatic spread by Butler, P.C., Potter, G.A.

    Published in Medical hypotheses (01-05-2001)
    “…The concept that non-haematological solid tumours utilize normal leukocyte mechanisms, specifically those of granulocytes, to facilitate metastatic spread is…”
    Get full text
    Journal Article
  6. 6

    Novel steroidal inhibitors of human cytochrome P45017α (17α-hydroxylase-C17,20-lyase) : potential agents for the treatment of prostatic cancer by POTTER, G. A, BARRIE, S. E, JARMAN, M, ROWLANDS, M. G

    Published in Journal of medicinal chemistry (23-06-1995)
    “…Steroidal compounds having a 17-(3-pyridyl) substituent together with a 16,17-double bond have been synthesized, using a palladium-catalyzed cross-coupling…”
    Get full text
    Journal Article
  7. 7

    Idoxifene: report of a phase I study in patients with metastatic breast cancer by COOMBES, R. C, HAYNES, B. P, DOWSETT, M, QUIGLEY, M, ENGLISH, J, JUDSON, I. R, GRIGGS, L. J, POTTER, G. A, MCCAGUE, R, JARMAN, M

    Published in Cancer research (Chicago, Ill.) (01-03-1995)
    “…Idoxifene, a novel antiestrogen with reduced estrogenic activity when compared to tamoxifen, has been given to 20 women with metastatic breast cancer, 19 of…”
    Get full text
    Journal Article
  8. 8

    The nanoflare model and stellar quiescent radio emission by Falla, D. F., Potter, A. G.

    “…The concept of the nanoflare, used in interpreting the solar X-ray corona, is extended to RS CVn stars which, unlike the Sun, exhibit non-thermal quiescent…”
    Get full text
    Journal Article
  9. 9

    The deuterium isotope effect for the alpha-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifen by Jarman, M, Poon, G K, Rowlands, M G, Grimshaw, R M, Horton, M N, Potter, G A, McCague, R

    Published in Carcinogenesis (New York) (01-04-1995)
    “…This study describes the application of on line HPLC-electrospray ionization MS in the structural determination of the metabolites formed following incubation…”
    Get more information
    Journal Article
  10. 10

    Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P450(17alpha) inhibitors by Barrie, S E, Haynes, B P, Potter, G A, Chan, F C, Goddard, P M, Dowsett, M, Jarman, M

    “…Two potent non-steroidal inhibitors (CB7645 and CB7661) of human cytochrome P450(17alpha) were tested for in vivo activity in WHT mice. There were no signs of…”
    Get full text
    Journal Article
  11. 11

    Rationally Designed Analogs of Tamoxifen with Improved Calmodulin Antagonism by Hardcastle, Ian R, Rowlands, Martin G, Houghton, John, Parr, Iris B, Potter, Gerard A, Jarman, Michael, Edwards, Karen J, Laughton, Charles A, Trent, John O, Neidle, Stephen

    Published in Journal of medicinal chemistry (01-01-1995)
    “…Computerized molecular modeling studies on the interactions of the antiestrogen tamoxifen (1) and its analogues bound to the calcium-binding protein calmodulin…”
    Get full text
    Journal Article
  12. 12

    Characterization of Atmospheric Ammonia Emissions from a Commercial Chicken House on the Delmarva Peninsula by Siefert, Ronald L, Scudlark, Joseph R, Potter, Amelia G, Simonsen, Kirsten A, Savidge, Karen B

    Published in Environmental science & technology (15-05-2004)
    “…A three-dimensional sampling grid using passive collectors was used to characterize the downwind gas-phase ammonia plumes originating from a commercial chicken…”
    Get full text
    Journal Article
  13. 13

    Pharmacokinetics and biodistribution of radiolabelled idoxifene: Prospects for the use of PET in the evaluation of a novel antioestrogen for cancer therapy by Young, H., Carnochan, P., Trivedi, M., Potter, G.A., Eccles, S.A., Haynes, B.P., Jarman, M., Ott, R.J.

    Published in Nuclear medicine and biology (01-05-1995)
    “…With a view to evaluating the role of PET imaging in the development of new anticancer drugs, we are investigating the novel antioestrogen…”
    Get full text
    Journal Article
  14. 14

    Effects of the potential chemopreventive agent DMU-135 on adenoma development in the ApcMin+ mouse by Sale, S, Tunstall, R G, Ruparelia, K C, Butler, P C, Potter, G A, Steward, W P, Gescher, A J

    Published in Investigational new drugs (01-11-2006)
    “…DMU-135 (3,4-Methylenedioxy-3',4',5'-trimethoxy chalcone) is a novel anticancer prodrug designed to be activated into a potent tyrosine kinase inhibitor by the…”
    Get full text
    Journal Article
  15. 15

    Esters of 3-pyridylacetic acid that combine potent inhibition of 17α-hydroxylase/C17,20-lyase (cytochrome P45017α) with resistance to esterase hydrolysis by ROWLANDS, M. G, BARRIE, S. E, CHAN, F, HOUGHTON, J, JARMAN, M, MCCAGUE, R, POTTER, G. A

    Published in Journal of medicinal chemistry (13-10-1995)
    “…Esters of 3- and 4-pyridylacetic acid have been prepared and tested for inhibitory activity toward the human testicular 17 alpha-hydroxylase/C17,20-lyase and…”
    Get full text
    Journal Article
  16. 16

    Development of a high performance zinc-62/copper-62 radionuclide generator for positron emission tomography by Zweit, J, Goodall, R, Cox, M, Babich, J W, Potter, G A, Sharma, H L, Ott, R J

    Published in European Journal of Nuclear Medicine (01-06-1992)
    “…Clinical utilisation of positron emission tomography could be enhanced by the availability of short-lived radionuclides derived from generator systems. The…”
    Get full text
    Journal Article
  17. 17

    3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancer by Chan, F C, Potter, G A, Barrie, S E, Haynes, B P, Rowlands, M G, Houghton, J, Jarman, M

    Published in Journal of medicinal chemistry (16-08-1996)
    “…Various 3- and 4-pyridylalkyl 1-adamantanecarboxylates have been synthesized and tested for inhibitory activity toward the 17 alpha-hydroxylase and…”
    Get full text
    Journal Article
  18. 18

    Contactless Nerve Stimulating Transducer by Hallgren, Richard C., Potter, A. G.

    “…Stimulation of nervous tissue by means of an induced electric field produced by a contactless device is described. The unit is unique because it lends itself…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Effects of the potential chemopreventive agent DMU-135 on adenoma development in the Apc super(Min+) mouse by Sale, S, Tunstall, R G, Ruparelia, K C, Butler, P C, Potter, G A, Steward, W P, Gescher, A J

    Published in Investigational new drugs (01-11-2006)
    “…DMU-135 (3,4-Methylenedioxy-3',4',5'-trimethoxy chalcone) is a novel anticancer prodrug designed to be activated into a potent tyrosine kinase inhibitor by the…”
    Get full text
    Journal Article